This issue of the ARCHIVES includes a focus on fibrates, with the publication of 2 articles, one an 18-year mortality follow-up report from the Helsinki Heart Study (HHS) and the other, a report on the role of bezafibrate in preventing the progression of insulin resistance.1,2 In an era dominated by statins (is there anything they cannot do?), it is timely to ask whatever became of the fibrates and what role, if any, they have in a statin world.
Bloomfield HE. The Role of Fibrates in a Statin World. Arch Intern Med. 2006;166(7):715-716. doi:10.1001/archinte.166.7.715